Our objective at Onxeo is to maintain an open, rich dialogue with our shareholders, our potential investors and the financial community at large. We keep you informed on a regular basis of the progress made by the Company in order to help you with your analysis and make it easier for you to understand the Company’s added value.

Agenda >

Bio International Convention

June 3-6, 2019

Portzamparc Midcap Conference

April 9-10, 2019

Market Solutions Forum by ESN (CM-CIC)

April 4-5, 2019

AACR 2019 – American Association for Cancer Research conference

March 29 – April 4, 2019